Ribavirin (Sandoz Inc)
Welcome to the PulseAid listing for the Ribavirin drug offered from Sandoz Inc. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | Ribavirin |
| SUBSTANCE NAME: | RIBAVIRIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2004-04-06 |
| END MARKETING DATE: | 0000-00-00 |
Ribavirin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ribavirin from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2004-04-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0781-2043_52ecf3bd-6c80-4361-804c-dac97bd735cb |
| PRODUCT NDC: | 0781-2043 |
| APPLICATION NUMBER: | ANDA076192 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers:
